Dean Investment Associates, LLC Bristol Myers Squibb CO Transaction History
Dean Investment Associates, LLC
- $688 Million
- Q4 2024
A detailed history of Dean Investment Associates, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dean Investment Associates, LLC holds 54,293 shares of BMY stock, worth $3.04 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
54,293
Previous 78,796
31.1%
Holding current value
$3.04 Million
Previous $4.08 Million
24.7%
% of portfolio
0.45%
Previous 0.56%
Shares
24 transactions
Others Institutions Holding BMY
# of Institutions
2,706Shares Held
1.54BCall Options Held
32MPut Options Held
34.2M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.37 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.33 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.38 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...